FDA approves first daily pill to drastically lower cholesterol levels
AI Summary
The FDA has approved Merck's Lipfendra, the first daily pill that significantly lowers cholesterol levels by blocking PCSK9 proteins, offering a new option for managing LDL-C. This development marks a significant step forward in the battle against heart disease, which remains a leading cause of death worldwide. While it's a promising alternative to existing treatments, patients and healthcare providers will need to weigh its benefits against potential side effects and overall cost effectiveness.
Original Source
Read the full article at Thehill →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.